Skip to main content
OpenTrials

Clinical trial condition

Choroidal Neovascularization

Explore clinical trials studying Choroidal Neovascularization. Study availability and eligibility vary by location and protocol.

150 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Choroidal Neovascularization trial results

Completed

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

NCT01580020

Conditions
Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +22 more
Locations
  • Novartis Investigative Site Leipzig, Germany
  • Novartis Investigative Site Regensburg, Germany
  • Novartis Investigative Site Augsburg, Germany
  • Novartis Investigative Site Bad Rothenfelde, Germany
View all 37 locations
View Trial Details
Completed

Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen

NCT01037348

Conditions
Choroid Diseases, Choroidal Neovascularisation, Choroidal Neovascularization, +9 more
Locations
  • Novartis Investigative Site Bristol, United Kingdom
  • Novartis Investigational Site City of London, United Kingdom
  • Novartis Investigative Site City of London, United Kingdom
  • Novartis Investigative Site City of London, United Kingdom
View Trial Details
Completed

Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

NCT00504959

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +10 more
Locations
  • Novartis Investigational Site Melbourne, Australia
  • Novartis Investigative Site Laken, Belgium
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Liège, Belgium
View all 36 locations
View Trial Details

Related conditions